CS
Chris Shibutani
#1135 out of 1699 analysts
Goldman Sachs
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
-0.25%
Gain +1.9%
Monthly
0.21%
Yearly
2.5%
Drawdown
73.73%
$621,358.58
Equity
Holdings
$510,124.69
Cash
$111,233.89
Investment
$590,756.46
$70,936.58
Profit +$11,576.2
Realized
$151,568.34
Unrealized
-$80,631.77
Dividends
$1,820.13
$111,233.89
Cash
Deposits
$550,422
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
1.9%
Profit
$11,576.2
Win %
0%
This Week
Compared To Last Week
Gain
-6.5%
Profit
-$43,217.83
Win %
0%
This Month
Compared to last month
Gain
-13.99%
Profit
-$101,098.84
Win %
0%
This Year
Compared to last year
Gain
-50.67%
Profit
-$638,234.68
Win %
0%
MCRB Seres Therapeutics, Inc.
+2.32%
+$11,576.2 No Data
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 113 | Longs Won 46/96 47% | Profit Factor 1.36 |
| Profitability | Shorts Won 15/17 88% | Standard Deviation $9,202.18 |
| Average Win $4,254.87 | Best Trade (Jan 19) $24,768.42 | Sharpe Ratio -229.62 |
| Average Loss -$3,662.13 | Worst Trade (Jun 19) -$77,198.48 | Z-Score -2.59 (100%) |
| Commissions $0 | Avg. Trade Length 2m 1w 2d | Expectancy $627.76 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | 0.02% | 0.18% | 0.94% | 3.84% | 13.01% | 38.17% |
| Consecutive Losing Trades | 170 | 153 | 136 | 119 | 102 | 85 | 68 | 51 | 34 | 17 |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
